A week before graduating, Columbia medical students in the VP&S Class of 2018 led a health and wellness fair at the Fort Washington Men’s Shelter.
Survivors of opioid overdose are more likely to die from respiratory diseases, viral hepatitis, and suicide—in addition to drug-related causes—than non-drug users, says a new study from Columbia Psychiatry.
Columbia neuroscientist Dr. Eric Kandel was a refugee who fled to the United States in 1939. In 2000, Dr. Kandel won the Nobel Prize in Medicine.
Columbia researchers discover that DNA repair falters when cells can’t move damaged DNA to repair centers within the nucleus. The results could lead to better cancer treatments.
Columbia scientists have developed a new computational framework that can support precision cancer treatment by matching individual tumors with the drugs most likely to kill them.
Four physician-scientists at the Vagelos College of Physicians and Surgeons have been named 2018 Gerstner Scholars and a fifth has been named a Gerstner Merit Awardee.
In one of the first studies of its kind, Columbia’s Philip De Jager shows how "big data" analyses may lead to new treatment strategies for Alzheimer's disease.
Adults taking medications with depression as a side effect were more likely to have depression, and the risk increased with the number of medications taken, a new study has found.
Two women entrepreneurs at Vagelos College of Physicians and Surgeons–Angela Christiano, PhD, and Tilla Worgall, MD–joined Columbia engineer Michal Lipson, PhD, to share their start-up experiences.
VP&S legend Virginia Apgar, MD'33, is most famous for creating the Apgar score, a fast and simple way to assess the health of newborn babies.
Cachexia, the debilitating muscle wasting that occurs in late-stage cancer patients, may be due to an overload of zinc in muscles, finds a new study.